Seminar

When:
February 17, 2012 @ 10:30 am โ€“ 11:30 am
2012-02-17T10:30:00-06:00
2012-02-17T11:30:00-06:00
Where:
W122-D3
Cullen College of Engineering Bldg 2
University of Houston, Houston, TX 77004
USA

Gene Regulation in Melanoma Metastasis:The Role of the Tumor Microenvironment
Menashe Bar-Eli Ph.D
Professor, Department of Cancer Biology
The University of Texas
MD Anderson Cancer Center

Abstract

The molecular changes associated with the transition of melanoma cells from radial growth phase (RGP) to vertical growth phase (VGP) and the metastatic phenotype are not very well defined. However, some of the genes involved in this process and their transcriptional regulation are beginning to be elucidated. For example, the switch from RGP to VGP and the metastatic phenotype is associated with loss of the AP-2ฮฑ transcription factor. AP-2ฮฑ regulates the expression of c-KIT, MMP-2, VEGF, and the adhesion molecule MCAM/MUC18. Recently, we reported that AP-2ฮฑ also regulates two G-protein coupled receptors (GPCRs) PAR-1 and PAFR. In turn, the thrombin receptor, PAR-1, regulates the expression of the gap junction protein Connexin-43 and the tumor suppressor gene Maspin. Activation of PAR-1 also leads to overexpression and secretion of proangiogenic factors such as IL-8, uPA, VEGF, PDGF, as well certain integrins. PAR-1 also cooperates with PAFR to regulate the expression of the MCAM/MUC18 via phosphorylation of CREB. The ligands for these GPCRs, thrombin and PAF, are secreted by stromal cells, emphasizing the importance of the tumor microenvironment in melanoma metastasis. The metastatic phenotype of melanoma is also associated with overexpression and function of CREB/ATF-1. Loss of AP-2ฮฑ and overexpression of CREB/ATF-1 results in the overexpression of MCAM/MUC18 which by itself contributes to melanoma metastasis by regulating the inhibitor of DNA binding-1 (Id-1). CREB/ATF-1 also regulates the angiogenic factor CYR-61. Our recent data indicate that CREB/ATF-1 regulates the expression of AP-2ฮฑ, thus, supporting the notion that CREB is an important “master switch” in melanoma progression.